158 related articles for article (PubMed ID: 34627500)
21. Access to Cytotoxic Medicines by Children With Cancer: A Focus on Low and Middle Income Countries.
Barr R; Robertson J
Pediatr Blood Cancer; 2016 Feb; 63(2):287-91. PubMed ID: 26375626
[TBL] [Abstract][Full Text] [Related]
22. Essential medicines out of reach for most people.
Indian J Med Sci; 2008 Dec; 62(12):520-1. PubMed ID: 19402257
[No Abstract] [Full Text] [Related]
23. Ensuring access to essential medicines: some economic considerations.
Maskus KE
Spec Law Dig Health Care Law; 2003 Jul; (291):9-25. PubMed ID: 15206162
[No Abstract] [Full Text] [Related]
24. Taking TRIPS to India--Novartis, patent law, and access to medicines.
Mueller JM
N Engl J Med; 2007 Feb; 356(6):541-3. PubMed ID: 17287473
[No Abstract] [Full Text] [Related]
25. Access to essential medicines to treat chronic respiratory disease in low-income countries.
Bissell K; Perrin C; Beran D
Int J Tuberc Lung Dis; 2016 Jun; 20(6):717-28. PubMed ID: 27155173
[TBL] [Abstract][Full Text] [Related]
26. Availability, cost and affordability of essential medicines for chronic respiratory diseases in low-income and middle-income countries: a cross-sectional study.
Stolbrink M; Ozoh OB; Halpin DMG; Nightingale R; Meghji J; Plum C; Allwood BW; Jayasooriya S; Mortimer K;
Thorax; 2024 Jun; 79(7):676-679. PubMed ID: 38760170
[TBL] [Abstract][Full Text] [Related]
27. What does it mean to put new hepatitis C drugs on a list of essential medicines?
Urrutia J; Porteny T; Daniels N
BMJ; 2016 Apr; 353():i2035. PubMed ID: 27106956
[No Abstract] [Full Text] [Related]
28. Unfunded promises as the UK health debate takes centre stage.
Lancet Oncol; 2010 May; 11(5):401. PubMed ID: 20409754
[No Abstract] [Full Text] [Related]
29. The selection and use of essential medicines. Report of the WHO expert committee, 2005 (including the 14th model list of essential medicines).
World Health Organ Tech Rep Ser; 2006; (933):1-119, back cover. PubMed ID: 17566509
[TBL] [Abstract][Full Text] [Related]
30. Differences in availability of cancer drugs across Europe.
Mayor S
Lancet Oncol; 2016 Sep; 17(9):1196. PubMed ID: 27476616
[No Abstract] [Full Text] [Related]
31. Consortium Outlines 3 Solutions to Maximize the Benefit and Affordability of Targeted Cancer Drugs.
Cancer; 2018 Aug; 124(16):3283. PubMed ID: 30141838
[No Abstract] [Full Text] [Related]
32. Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology.
Saeed A; Saeed H; Saleem Z; Fang Y; Babar ZU
PLoS One; 2019; 14(4):e0216122. PubMed ID: 31022276
[TBL] [Abstract][Full Text] [Related]
33. Access to medicines versus access to treatment: the case of type 1 diabetes.
Beran D; McCabe A; Yudkin JS
Bull World Health Organ; 2008 Aug; 86(8):648-9. PubMed ID: 18797626
[No Abstract] [Full Text] [Related]
34. The selection and use of essential medicines.
WHO Expert Committee
World Health Organ Tech Rep Ser; 2008; (950):backcover, vii-174. PubMed ID: 18754303
[TBL] [Abstract][Full Text] [Related]
35. A multidisciplinary review of the policy, intellectual property rights, and international trade environment for access and affordability to essential cancer medications.
Baxi SM; Beall R; Yang J; Mackey TK
Global Health; 2019 Sep; 15(1):57. PubMed ID: 31533850
[TBL] [Abstract][Full Text] [Related]
36. The high price of cancer drugs: enough is enough.
Prescrire Int; 2015 Jan; 24(156):27. PubMed ID: 25729840
[TBL] [Abstract][Full Text] [Related]
37. Policies and programs to facilitate access to targeted cancer therapies in Thailand.
Sruamsiri R; Ross-Degnan D; Lu CY; Chaiyakunapruk N; Wagner AK
PLoS One; 2015; 10(3):e0119945. PubMed ID: 25798948
[TBL] [Abstract][Full Text] [Related]
38. Targeted immunotherapies overtaking emerging oncology market value based growth.
Jakovljevic MB
J BUON; 2015; 20(1):350-1. PubMed ID: 25778340
[No Abstract] [Full Text] [Related]
39. Innovation and the WHO's essential medicines list: giving credit where credit is due.
Wertheimer AI; Santella TM
Res Social Adm Pharm; 2007 Mar; 3(1):137-44. PubMed ID: 17350562
[No Abstract] [Full Text] [Related]
40. Country and regional variations in purchase prices for essential cancer medications.
Cuomo RE; Seidman RL; Mackey TK
BMC Cancer; 2017 Aug; 17(1):566. PubMed ID: 28836947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]